ABI launches new miRNA expression arrays
Applied Biosystems (ABI) has launched its TaqMan microRNA (miRNA) assays in array format to help researchers search for miRNA biomarkers more efficiently from smaller samples.
Applied Biosystems (ABI) has launched its TaqMan microRNA (miRNA) assays in array format to help researchers search for miRNA biomarkers more efficiently from smaller samples.
Despite the hype, countries in emerging markets are still very much trailing behind the US in the number of Food and Drug Administration (FDA)-approved studies being conducted, particularly the Asia-pacific, a survey by Parexel reveals.
Biocatalysis expert Codexis has acquired BioCatalytics for an undisclosed amount to strengthen its off-the-shelf biocatalyst portfolio and give itself a larger 'window to the market'.
MedImmune has announced that interim Phase I results for its new monoclonal antibody (MAb) suggest that it is well tolerated and shows biological activity in adults with asthma.
The field of oral controlled release drug delivery is constantly evolving and developing, allowing ever more precise and tailored delivery profiles for pharmaceutical drugs.
Ever since Bio-Rad's acquisition of Ciphergen's SELDI MS (surface enhanced laser desorption/ionisation mass spectrometry) technology late last year, it has been fighting against the spectre of "controversial" research results obtained using the...